American Kidney Fund Announces Support from Vertex Pharmaceuticals Inc. to Raise Awareness and Increase Education of the APOL1 Gene and its Link to Kidney Disease
AKF is pleased to announce that Vertex Pharmaceuticals Inc. is providing support for its education and awareness campaign about the apolipoprotein L1 (APOL1) ge...
American Kidney Fund Releases 2022 Living Donor Protection Report Card, Highlighting Need for Federal Protections for All U.S. Donors
Second annual Report Card highlights progress among states, but more needs to be done to protect those giving the gift of life
American Kidney Fund Announces 2022 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
AKF announces the 2022 class of Members in its Corporate Membership Program.
American Kidney Fund Earns 20th Consecutive Highest, 4-Star Rating from Charity Navigator, Platinum Seal of Transparency from Candid
AKF's strong financial health and commitment to accountability and transparency cited by Charity Navigator, world's largest nonprofit evaluator
American Kidney Fund Awards Two Clinical Scientist in Nephrology Fellowships to Researchers Focused on Disparities in Kidney Transplants, Genetic Variants in Nephrotic Syndrome
Researchers from Stanford University School of Medicine, Brigham and Women's Hospital and Massachusetts General Hospital will study health disparities, ren...
The American Kidney Fund is pleased to announce the addition of five new members to its national volunteer Board of Trustees.
March is Kidney Month, and the American Kidney Fund (AKF) is inviting members of the kidney community to join the celebration by sharing their "kidney mome...
American Kidney Fund Debuts New Website Designed to Educate, Empower, and Engage Millions Affected by Kidney Disease
The American Kidney Fund (AKF) is pleased to announce its redesigned website, KidneyFund.org. The new website further enhances AKF's 50+ year commitment to...
If passed, AB 2504 would be the first law of its kind in the nation